FibroGen (FGEN) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. MRVL
10. MTCH

Go back to FibroGen (FGEN) Tops Q4 EPS by 2c

FibroGen (FGEN) PT Lowered to $79 at Stifel

February 28, 2018 6:27 AM EST

Stifel lowered its price target on FibroGen (NASDAQ: FGEN) to $79.00 (from $80.00) while maintaining a Buy rating following Q4 results.

Analyst Alex Schwartz noted for chronic kidney disease (CKD) anemia with roxadustat, the company now guided topline data in the U.S. during 4Q18 and an NDA filing in 1H19.

... More